IQVIA Holdings's revenue for the
three
months ended in Sep. 2024 was $3,896 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $15,315 Mil.
IQVIA Holdings's Revenue per Share for the
three
months ended in Sep. 2024 was $21.15.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $83.09.
Warning Sign:
IQVIA Holdings Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of IQVIA Holdings was 4.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, IQVIA Holdings's highest 3-Year average Revenue per Share Growth Rate was 12.50% per year. The lowest was 1.50% per year. And the median was 7.40% per year.
IQVIA Holdings Revenue Historical Data
The historical data trend for IQVIA Holdings's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IQVIA Holdings's Revenue
For the Diagnostics & Research subindustry, IQVIA Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IQVIA Holdings's Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Revenue distribution charts can be found below:
* The bar in red indicates where IQVIA Holdings's Revenue falls into.
IQVIA Holdings Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $15,315 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IQVIA Holdings (NYSE:IQV) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
IQVIA Holdings Revenue Related Terms
Thank you for viewing the detailed overview of IQVIA Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IQV has been successfully added to your 